Science Blog

Lipoic Acid as Adjunctive Treatment for Schizophrenia

PURPOSE/BACKGROUND: Accumulating evidence suggests an involvement of oxidative stress in the pathophysiology of schizophrenia. This offers a hypothesis-derived therapeutic approach to hinder oxidative damage and its clinical sequelae. α-Lipoic acid (ALA) is a powerful natural antioxidant indicated to treat diabetic neuropathy. METHODS/PROCEDURES: In this pilot investigation, we administered ALA (100 mg/d) for 4 months, as […]

November 15, 2017 Consumer Blog By GeroNova Research

Effect of Lipoic Acid in Preventing the Genesis of Canine Diabetic Cataract: A Preliminary Study.

Blinding cataract is a significant effect of canine diabetes with 75% of animals affected two years after diagnosis. Lens opacification occurs primarily through the generation of sorbitol, a sugar alcohol, through the action of aldose reductase (AR). The osmotic effect of sorbitol draws water into the lens, causing opacification. Inhibition of AR should thus prevent […]

November 15, 2017 Consumer Blog By GeroNova Research

Modulatory effects of lipoic acid on insulin sensitivity in obese Polycystic ovary syndrome (PCOS) patients

PURPOSE: To evaluate the efficacy of alpha-lipoic acid (ALA) administration on hormonal and metabolic parameters of obese PCOS patients. METHODS: A group of 32 obese PCOS patients were selected after informed consent. 20 patients referred to have first grade relatives with diabetes type I or II. Hormonal and metabolic parameters as well as OGTT were […]

November 15, 2017 Consumer Blog By GeroNova Research

Lipoic acid may be useful for preventing atherosclerosis at therapeutic doses.

Effect of lipoic acid on paraoxonase-1 and paraoxonase-3 protein levels, mRNA expression and arylesterase activity in liver hepatoma cells. Abstract Paraoxonase-1 (PON1) and PON3 (PON3) are anti-atherosclerotic enzymes, synthesized primarily in liver and bound to HDL in circulation. The aim of the present study was to investigate the effects of therapeutic doses of lipoic acid […]

July 28, 2017 Consumer Blog By GeroNova Research

Lipoic Acid Pharmacokinetics at Baseline and 1 year in Secondary Progressive MS

Lipoic acid (LA) is a water- and fat-soluble oral antioxidant with anti-inflammatory properties. It has demonstrated benefits in animal models of MS and has been evaluated for MS relapse prevention and neuroprotection. However, there are relatively a few data regarding LA pharmacokinetics (PK) in elderly populations or with use beyond 4 days.1 In addition, studies […]

July 28, 2017 Consumer Blog By GeroNova Research

More Articles